Evidence map›Paper›PMID 30655707›Full record

ArticleClinical epidemiology2019

Central nervous system tumor registration in the Swedish Cancer Register and Inpatient Register between 1990 and 2014.

Giorgio Tettamanti, Rickard Ljung, Anders Ahlbom, Mats Talbäck, Birgitta Lannering, Tiit Mathiesen, Jenny Pettersson Segerlind, Maria Feychting

Open access · goldAbstract read
In one paragraph

Article in Clinical epidemiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Giorgio TettamantiUnit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, giorgio.tettamanti@ki.se.
Rickard LjungUnit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, giorgio.tettamanti@ki.se.
Anders AhlbomUnit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, giorgio.tettamanti@ki.se.
Mats TalbäckUnit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, giorgio.tettamanti@ki.se.
Birgitta LanneringPediatric Oncology, Department of Clinical Sciences, University of Gothenburg, Gothenburg, Sweden.
Tiit MathiesenDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Jenny Pettersson SegerlindDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Maria FeychtingUnit of Epidemiology, Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden, giorgio.tettamanti@ki.se.
Karolinska Institutet · SEUniversity of Copenhagen · DKUniversity of Gothenburg · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Swedish Cancer Register (SCR) is characterized by excellent quality and completeness overall, but the quality of the reporting may vary according to tumor site and age, and may change over time. The aim of the current study was to investigate the completeness of the reporting of central nervous system (CNS) tumor cases to the SCR. MATERIALS AND

methodsIndividuals hospitalized for a CNS tumor between 1990 and 2014 were identified using the Inpatient Register; the proportion of identified cases that did not have any cancer diagnosis reported to the SCR was subsequently assessed.

resultsBetween 1990 and 2014, 58,698 individuals were hospitalized for a CNS tumor, and a large proportion of them did not have any cancer diagnosis reported to the SCR (26%). This discrepancy was particularly pronounced for benign tumors and among elderly patients (over 30%). It was substantially lower for malignant brain tumors among adults (10%); moreover, no increase in the discrepancy between the two registers was observed in this group during the study period. Similar findings were found when assessing the concordance between the Cause of Death Register and the SCR. Among CNS tumor patients who were not reported to the SCR, a large proportion had only one hospital discharge diagnosis containing a CNS tumor (35%) and were less likely to be found in the Outpatient Register, which indicates that a large proportion of patients may have received an erroneous diagnosis.

conclusionWhile a large proportion of CNS tumor patients were not reported to the SCR, the discrepancy between the SCR and the Inpatient Register was relatively small for malignant brain tumors among adults and has remained stable throughout the study period. We do not recommend that data from the Inpatient Register are combined with the SCR to estimate CNS tumor incidence, without proper confirmation of the diagnoses, as a considerable proportion of CNS tumor diagnoses registered in the Inpatient Register is unlikely to reflect true CNS tumors.

Indexed as

brain neoplasmscentral nervous system neoplasmsregistriesSweden

Identifiers

PMID30655707
PMCPMC6324922
OpenAlexW2907206869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.